Description
Product Description:
Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase domains of both EGFR (ErbB1) and of HER2 (ErbB2) receptors. Lapatinib retained significant activity against HER2-amplified breast cancer cell lines selected for long-term growth in trastuzumab-containing medium in vitro and was synergistic in combination with trastuzumab in these cell lines.
Product Features:
| Product Name | : | Lapanix |
| Generic Name | : | Lapatinib |
| Formulation | : | Tablet |
| Available Pack Size | : | 150’s Pot |
| Available Strength | : | 250 mg |
| Registrations | : | Export Only |
Reviews
There are no reviews yet.